Cancer Home > Eribulin Dosage
For people with breast cancer who are undergoing chemotherapy treatment with eribulin, dosing recommendations will be based on several factors. Some of these factors include your weight and height, and how you respond to the medication. This medication is administered intravenously (by IV) on day 1 and day 8 of a 21-day cycle.
An Introduction to Your Dosage of EribulinThe dose of eribulin mesylate (Halaven™) your healthcare provider recommends will vary, depending on factors such as:
- Your height
- Your weight
- Your kidney and liver function
- How you respond to the medication.
As is always the case, do not adjust your dosage unless your healthcare provider specifically tells you to do so.
Eribulin Dosing for Breast CancerYour healthcare provider will base your dose on your body surface area, which is calculated using your height and weight. If you develop dangerous eribulin side effects, your healthcare provider may need to lower your dosage and/or delay future treatments. The medication is typically given on day 1 and day 8 of a 21-day cycle.
If your liver or kidney function is not optimal, your healthcare provider may recommend a lower-than-normal dosage of eribulin.
General Information on Receiving EribulinSome considerations to keep in mind during treatment with eribulin include the following:
- This medication is administered intravenously (by IV) within just a few minutes. However, the entire process will typically take much longer.
- Chemotherapy works best if you can receive it on schedule. However, if you develop serious side effects, your treatments may need to be postponed.
- If you are unsure about anything related to dosing with eribulin, please talk with your healthcare provider, nurse, or pharmacist.